AIM: AIM ImmunoTech Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
1 open-market buys totaling $5K and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 20 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO | 2026-10-22 | $5K | 25% |
Institutional ownership (Q2 2026)
19 institutions reported holding $291K of AIM ImmunoTech Inc. on Form 13F (18 the quarter before). 4 opened a new position and 3 sold out. Shares held by institutions: +935%.
| Largest holders | Shares | Value |
|---|---|---|
| JANE STREET GROUP, LLC | 807,885 | $229K |
| MORGAN STANLEY | 50,864 | $14K |
| GEODE CAPITAL MANAGEMENT, LLC | 46,003 | $13K |
| GOLDMAN SACHS GROUP INC | 32,444 | $9K |
| UBS Group AG | 28,931 | $8K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 21,859 | $6K |
| VANGUARD FIDUCIARY TRUST CO | 17,519 | $5K |
| Ground Swell Capital, LLC | 12,222 | $3K |
| Tower Research Capital LLC (TRC) | 4,668 | $1K |
| Continuum Advisory, LLC | 500 | $142 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.